当前位置:首页 - 行情中心 - 苑东生物(688513) - 财务分析 - 现金流量表

苑东生物

(688513)

  

流通市值:99.37亿  总市值:99.37亿
流通股本:1.77亿   总股本:1.77亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,099,079,014.31740,212,954.98363,135,826.361,423,588,372.39
  收到的税费返还903,364.0244,867.2514,955.7511,618,077.87
  收到其他与经营活动有关的现金59,931,204.4742,655,401.2415,447,523.86115,564,853.06
  经营活动现金流入小计1,159,913,582.8782,913,223.47378,598,305.971,550,771,303.32
  购买商品、接受劳务支付的现金201,109,790.85120,227,395.0159,460,936.29272,424,977.15
  支付给职工以及为职工支付的现金248,916,233.01177,142,813.26103,426,617.83299,121,565.59
  支付的各项税费103,803,434.3872,084,393.331,992,808.24158,666,814.46
  支付其他与经营活动有关的现金387,265,933.86255,985,963.4134,760,143.84557,317,576.87
  经营活动现金流出小计941,095,392.1625,440,564.97329,640,506.21,287,530,934.07
  经营活动产生的现金流量净额218,818,190.7157,472,658.548,957,799.77263,240,369.25
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,452,140.551,370,128.38-493,869.86
  收到的其他与投资活动有关的现金625,174,486.68614,130,682.91281,557,404.752,251,187,606.14
  投资活动现金流入小计626,626,627.23615,500,811.29281,557,404.752,251,681,476
  购建固定资产、无形资产和其他长期资产支付的现金57,026,332.932,724,421.8312,267,277.9117,423,923.05
  投资支付的现金19,680,000--1,500,000
  支付其他与投资活动有关的现金1,136,113,471.66880,698,104.99820,598,104.991,936,126,625
  投资活动现金流出小计1,212,819,804.56913,422,526.82832,865,382.892,055,050,548.05
  投资活动产生的现金流量净额-586,193,177.33-297,921,715.53-551,307,978.14196,630,927.95
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,536,983.689,536,983.68-34,759,466.97
  取得借款收到的现金35,000,00035,000,00010,000,000150,000,000
  收到其他与筹资活动有关的现金135,749,961.385,477,714.8743,275,359.969,999,987.5
  筹资活动现金流入小计180,286,944.98130,014,698.5553,275,359.96194,759,454.47
  偿还债务支付的现金71,466,666.6771,466,666.6720,000,000253,923,333.34
  分配股利、利润或偿付利息支付的现金76,727,234.4276,151,625.18672,983.3674,107,631.6
  支付其他与筹资活动有关的现金69,699,657.394,454,116.424,454,116.42128,993,902.4
  筹资活动现金流出小计217,893,558.48152,072,408.2725,127,099.78457,024,867.34
  筹资活动产生的现金流量净额-37,606,613.5-22,057,709.7228,148,260.18-262,265,412.87
四、汇率变动对现金及现金等价物的影响-194,430.12,612.2318,950.7631,963.75
五、现金及现金等价物净增加额-405,176,030.23-162,504,154.52-474,182,967.43197,637,848.08
  加:期初现金及现金等价物余额965,178,505.19965,178,505.19965,178,505.19767,540,657.11
  期末现金及现金等价物余额560,002,474.96802,674,350.67490,995,537.76965,178,505.19
补充资料:
  净利润-136,571,926.08-238,234,159.3
  资产减值准备-1,079,831.19-5,698,289.79
  固定资产和投资性房地产折旧-40,141,829.21-80,612,312.26
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-40,141,829.21-80,612,312.26
  无形资产摊销-1,212,076.2-2,223,734.26
  长期待摊费用摊销-636,069.74-1,674,586.29
  处置固定资产、无形资产和其他长期资产的损失---2,992.06
  固定资产报废损失-20,983.86-109,753.41
  公允价值变动损失--6,835,167.13--14,923,057.38
  财务费用-1,275,243.07-3,616,074.27
  投资损失--4,047,937.64--9,841,891.62
  递延所得税-1,850,656.37--2,686,136.69
  其中:递延所得税资产减少-1,339,583.11--2,933,751.18
    递延所得税负债增加-511,073.26-247,614.49
  存货的减少--25,638,050.98--34,803,016.51
  经营性应收项目的减少-28,915,103.3--112,437,411.52
  经营性应付项目的增加--33,109,363.55-82,731,163.18
  其他-14,886,582.65-19,976,151.87
  现金的期末余额-802,674,350.67-965,178,505.19
  减:现金的期初余额-965,178,505.19-767,540,657.11
  现金及现金等价物的净增加额--162,504,154.52-197,637,848.08
公告日期2025-10-282025-08-192025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑